Overview
Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH). It is primarily used to treat HIV-associated lipodystrophy, a condition characterized by excess abdominal fat. Tesamorelin stimulates the pituitary gland to release growth hormone, which helps reduce abdominal fat and improve metabolic parameters.
Originally developed to combat the effects of lipodystrophy in HIV patients, Tesamorelin has also garnered attention for its potential anti-aging and performance-enhancing effects. It mimics the action of natural GHRH, promoting a more youthful hormonal profile.
Mechanism of Action
Tesamorelin works by binding to GHRH receptors in the pituitary gland, stimulating the release of endogenous growth hormone (GH). This release of GH leads to downstream effects, including increased levels of insulin-like growth factor 1 (IGF-1) in the liver. The increased GH and IGF-1 levels promote lipolysis (fat breakdown) and can improve glucose metabolism.
Unlike direct GH administration, Tesamorelin stimulates a more pulsatile and natural release of growth hormone. This can lead to a reduced risk of side effects associated with synthetic GH, while still providing significant metabolic benefits.
Key Benefits
- Reduction of abdominal fat
- Improved metabolic parameters (e.g., glucose metabolism)
- Increased lean body mass
- Potential anti-aging effects
Research & Indications
The primary FDA-approved indication for Tesamorelin is the treatment of HIV-associated lipodystrophy. Clinical trials have demonstrated its effectiveness in reducing visceral adipose tissue (VAT) in these patients. Research also explores Tesamorelin's potential benefits in healthy aging, including improvements in body composition and cognitive function.
Studies have shown that Tesamorelin can improve memory and cognitive performance in older adults with mild cognitive impairment. Additionally, ongoing research investigates its potential role in treating other metabolic disorders and age-related conditions.
Dosing Protocols
Disclaimer: The following dosing information is for research purposes only and does not constitute medical advice. Consult with a qualified healthcare professional before using Tesamorelin.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Reduction of Abdominal Fat | 2 mg | Once daily | Subcutaneous |
Supplies Needed
For an 8-week protocol:
- Peptide Vials: 6 vials of 2mg each
- Insulin Syringes (U-100): 56 syringes (1 per day)
- Bacteriostatic Water: 1 × 10mL bottle
- Alcohol Swabs: 56 alcohol swabs
Side Effects & Safety
Common side effects of Tesamorelin may include injection site reactions (redness, swelling, itching), joint pain, and fluid retention. Less common side effects can include increased blood sugar levels and carpal tunnel syndrome. It is contraindicated in individuals with active cancer, pituitary disorders, or hypersensitivity to Tesamorelin.
Storage & Handling
Tesamorelin should be stored in lyophilized form at refrigerated temperatures (2-8°C). Once reconstituted with bacteriostatic water, it should be used within a few weeks and stored in the refrigerator.